title: Targeting VEGF signalling via the neuropilin co-receptor.
abstract: The blockade of tumour vascularisation and angiogenesis continues to be a focus for drug development in oncology and other pathologies. Historically, targeting vascular endothelial growth factor (VEGF) activity and its association with VEGF receptors (VEGFRs) has represented the most promising line of attack. More recently, the recognition that VEGFR co-receptors, neuropilin-1 and -2 (NRP1 and NRP2), are also engaged by specific VEGF isoforms in tandem with the VEGFRs has expanded the landscape for the development of modulators of VEGF-dependent signalling. Here, we review the recent structural characterisation of VEGF interactions with NRP subdomains and the impact this has had on drug development activity in this area.
authors.affiliation: Department of Structural and Molecular Biology, Institute of Structural and Molecular Biology, University College London, Gower Street, London WC1E 6BT, UK. s.djordjevic@ucl.ac.uk
authors.forename: Snezana
authors.initials: S
authors.lastname: Djordjevic
authors.forename: Paul C
authors.initials: PC
authors.lastname: Driscoll
mesh_terms: D000818:Animals; D006801:Humans; D009389:Neovascularization, Pathologic / Q000378:metabolism; D039921:Neuropilins / Q000737:chemistry / Q000378:metabolism*; D011487:Protein Conformation; D040262:Receptors, Vascular Endothelial Growth Factor / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: D039921:Neuropilins; D042461:Vascular Endothelial Growth Factor A; D040262:Receptors, Vascular Endothelial Growth Factor